TRANSPLANTATION PROCEEDINGS is a distinguished journal published by Elsevier Science Inc, focused on the field of transplantation and surgery. With a publication history spanning over five decades, from 1969 to 2024, this journal has consistently provided a platform for researchers and practitioners to share significant findings and advancements in organ transplantation and related surgical techniques. The journal is renowned for its rigorous peer-review process and has achieved a respectable impact factor within its categories, ranking in the Q3 quartile for both Surgery and Transplantation as of 2023. With Scopus rankings placing it in the 47th percentile in Medicine (Surgery) and the 43rd percentile in Medicine (Transplantation), TRANSPLANTATION PROCEEDINGS serves as a vital resource for academics and medical professionals seeking to stay updated on the latest empirical research, clinical practices, and innovative methodologies in the field. While it does not operate under an open-access model, the journal ensures that critical insights and data are accessible to its audience, enhancing the global discourse in transplantation science. For those dedicated to advancing transplant medicine, this journal represents an invaluable collection of knowledge and a forum for fostering innovative approaches to improve patient outcomes.

Transplant Immunology is a leading interdisciplinary journal published by Elsevier, dedicated to the advancing field of transplant science and immunology. With a strong reputation in the academic community, it currently holds a significant position in the Q3 quartile in both the Immunology and Allergy categories, as well as Q2 in Transplantation, reflecting its impact and relevance within these fields. Since its inception in 1993, the journal has explored a broad spectrum of topics, ranging from immunological mechanisms to clinical aspects of transplantation, serving as a vital resource for researchers, healthcare professionals, and students alike. Although it is not an open-access journal, it offers critical insights and innovative research findings that bridge theoretical knowledge and practical application, thereby enhancing our understanding of transplant immunology. As the field continues to evolve, Transplant Immunology remains committed to publishing high-quality studies that advance the dialogue between immunology and transplantation, fostering collaboration and discovery.

THORACIC AND CARDIOVASCULAR SURGEON, published by GEORG THIEME VERLAG KG, is a prestigious journal dedicated to the fields of cardiology, cardiovascular surgery, and pulmonary medicine. Since its inception in 1973, the journal has served as a vital platform for disseminating cutting-edge research and innovative techniques, contributing significantly to advancements in patient care and surgical practices. With an emerging recognition evidenced by its category quartiles, ranking Q3 in Cardiology and Cardiovascular Medicine and Q2 in Surgery as of 2023, it positions itself as an essential resource for both clinicians and researchers alike. Although this journal does not currently offer Open Access options, it maintains a strong impact with Scopus rankings that highlight its relevance within the medicine and surgery disciplines. The journal is particularly committed to bridging the gap between theoretical research and practical application, making it crucial for professionals aiming to stay informed on the latest developments in thoracic and cardiovascular health. Join a community of scholars dedicated to excellence in these critical areas of medicine.

Experimental and Clinical Transplantation is a distinguished journal published by Baskent University in Turkey, dedicated to advancing the field of transplantation through innovative research and clinical insights. Established in 2003, the journal has rapidly gained recognition within the academic community, currently holding a Q3 ranking in the field of Transplantation for 2023, as evidenced by its position in the Scopus ranking for the discipline. With an emphasis on both experimental and clinical studies, this journal serves as a crucial platform for sharing breakthroughs in transplant medicine, immunology, and post-operative care strategies. Although it operates under a restricted access policy, the journal seeks to bridge the gap between research findings and practical applications in clinical settings, making it invaluable for researchers, healthcare professionals, and students alike who are keen on exploring advancements in the transplantation landscape. Through its commitment to quality and innovation, Experimental and Clinical Transplantation contributes significantly to enhancing patient outcomes and fostering scholarly dialogue in the transplantation community.

Indian Journal of Transplantation (ISSN: 2212-0017, E-ISSN: 2212-0025), published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the expanding field of transplantation medicine. As an Open Access journal since 2011, it provides unrestricted access to cutting-edge research, facilitating the dissemination of knowledge among practitioners, researchers, and students globally. With a growing focus on transplant-related advancements from 2020 to 2024, the journal has positioned itself within the Q4 category in Transplantation, underscoring its commitment to publishing valuable contributions that aim to enhance clinical practices and improve patient outcomes. Situated in the Netherlands, the journal upholds high-quality standards, inviting submissions that contribute to the understanding of various transplant procedures and practices, ultimately fostering innovation in the field. Researchers and professionals are encouraged to explore the vast array of articles, enhancing both their expertise and the community's collective knowledge in transplantation.

CELL TRANSPLANTATION is a premier multidisciplinary journal dedicated to advancing the field of regenerative medicine and transplantation, published by SAGE PUBLICATIONS INC. Since its initiation in 1992 and embracing an open-access model since 2017, the journal aims to disseminate high-quality research that covers both clinical and experimental studies on cell and tissue transplantation. With a notable impact reflected in its 2023 Q2 ranking in Biomedical Engineering and significant standings in Cell Biology and Transplantation, CELL TRANSPLANTATION serves as a vital resource for researchers, practitioners, and students alike. The journal's commitment to fostering innovation is evident in its diverse contributions that address the complexities of tissue engineering, immunology, and regenerative therapies, inviting readers to engage with cutting-edge science that is poised to transform medical practices and improve patient outcomes. The journal's insightful articles and research findings make it a crucial platform for knowledge exchange within the vibrant scientific community.

Clinical Transplantation is a leading journal in the field of transplantation medicine, published by Wiley. With an ISSN of 0902-0063 and an E-ISSN of 1399-0012, this prestigious journal has been pivotal in advancing the understanding of clinical practices and innovative research in transplantation since its inception in 1989. Based in the United Kingdom, it is recognized within the Category Quartiles as Q2 in Transplantation and boasts a respectable Scopus rank, placing it #20 out of 54 in its field, highlighting its significance. The journal serves as a platform for disseminating peer-reviewed articles that encompass a wide range of topics, from organ transplantation techniques to post-operative care and immunology, catering to researchers, healthcare professionals, and students alike. As the field progresses towards more personalized and effective treatment approaches, Clinical Transplantation remains committed to providing insight and fostering excellence in research for the global transplantation community.

Transplantation Reviews is a premier scholarly journal published by Elsevier Science Inc, dedicated to advancing the field of transplantation and surgery. With an impressive impact factor and categorized in the top quartile (Q1) for both Surgery and Transplantation as of 2023, this journal prominently ranks in the 96th and 86th percentiles for its respective disciplines. Since its inception in 1987, it has provided a vital platform for researchers and professionals to disseminate high-quality, peer-reviewed articles that reflect the latest advancements and challenges in transplantation science. Although the journal is not currently open access, it remains a key resource for academic libraries and institutions. By fostering discussions and providing insights into clinical practices, Transplantation Reviews serves to enhance understanding and improve outcomes in the ever-evolving field of transplantation, making it an essential read for anyone engaged in this dynamic area of medicine.

Pediatric Transplantation is a prestigious academic journal published by Wiley, focusing on the critical field of pediatric organ transplantation. Since its inception in 1997, the journal has played a pivotal role in disseminating groundbreaking research and clinical insights relevant to pediatric health, including both pediatrics and transplantation disciplines. With an impact factor that reflects its significance—ranking in the second quartile (Q2) within both Pediatrics, Perinatology and Child Health and Transplantation categories—it provides a vital platform for researchers and clinicians dedicated to improving outcomes for pediatric transplant patients. Pediatric Transplantation embraces a wide scope of studies, from basic science to clinical trials, promoting collaborations that enhance the well-being of young organ recipients. Published in the United Kingdom, this journal does not operate under an open access model, ensuring that the content is peer-reviewed and of the highest academic rigor. For professionals and scholars seeking to stay at the forefront of pediatric transplantation advancements, Pediatric Transplantation serves as an invaluable resource.

Seminars in Thoracic and Cardiovascular Surgery, published by Elsevier Inc, is a prestigious journal that focuses on advancing the fields of thoracic and cardiovascular surgery, cardiology, and pulmonary medicine. With a strong impact factor and an impressive reputation indicated by its 2023 rankings as Q2 in Cardiology and Cardiovascular Medicine, and Q1 in both Medicine (miscellaneous) and Surgery, the journal occupies a critical space in the academic landscape. Established in 1989, it has become a vital resource for researchers, clinicians, and students alike, fostering innovation through comprehensive reviews and cutting-edge studies. Although it does not offer open access, its robust editorial standards ensure that published articles contribute significantly to the ongoing discourse in surgical techniques and procedural advancements. Researchers and practitioners are encouraged to explore its rich compendium of peer-reviewed content that informs clinical practices and guides future investigations in the dynamic and evolving realm of thoracic and cardiovascular health.